FHRX First Horizon Pharmaceutical (MM)

First Horizon Pharmaceutical Corporation ("First Horizon") (NasdaqNM: FHRX) today announced its growing partnership with Bayer Healthcare AG ("Bayer"). First Horizon amended its agreement with Bayer on January 6, 2006, that contemplates a growing partnership allowing for improved pricing for Federal programs to increase sales; foreign currency exchange rate protection; and the opportunity for expanded international distribution rights for Sular. "We are delighted to announce our continued growing partnership with Bayer," said Patrick Fourteau, First Horizon's President and Chief Executive Officer. "This agreement for Sular plays an important role in allowing First Horizon to grow its business and service our expanded federal programs emphasis profitably. We will also be able to look at expanding into international markets with Bayer's help. " About First Horizon First Horizon Pharmaceutical Corporation is a specialty pharmaceutical company that markets, sells and develops prescription products with a primary focus on cardiology and women's health. First Horizon has a portfolio that includes 15 branded prescription products of which 8 are actively promoted to high-prescribing physicians through its recently expanded nationwide sales force of approximately 525 representatives. First Horizon's web sit address is: www.fhrx.com. Pease visit First Horizon's website for full prescribing information on First Horizon's products.